Page 3 - Hudson Global News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Research Analysts’ new coverage for Sunday, May 5th: StockNews.com initiated coverage on shares of CymaBay Therapeutics (NASDAQ:CBAY). They issued a sell rating on the stock. StockNews.com started coverage on shares of Cellectis (NASDAQ:CLLS). The firm issued a sell rating on the stock. StockNews.com began coverage on shares of ClearOne (NASDAQ:CLRO). They issued a buy rating […]

Research analystTonix pharmaceuticalsWyndham hotels resortsNews ratings for cymabay therapeutics inc dailySignature bankRepublic first bancorpHaynes internationalTaro pharmaceutical industriesRecon technologyMarine petroleum trustMexco energyDiversity networkCymabay therapeutics incCymabay therapeuticsDelta apparelHudson global